A carregar...
Abciximab-induced alveolar hemorrhage after percutaneous coronary intervention
Abciximab, a platelet glycoprotein (GP) IIb/IIIa inhibitor, has been shown to improve clinical outcomes in patients undergoing percutaneous coronary intervention. However, there is a well-documented increase in bleeding risk associated with the use of this agent. Spontaneous pulmonary hemorrhage is...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Pulsus Group Inc
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2644574/ https://ncbi.nlm.nih.gov/pubmed/18273491 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|